Cel Sci CVM
NYSE CVM
$2.26 +0.18 (+8.65%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cel Sci (CVM) Revenue (2010 - 2017)

Updated

Cel Sci's Revenue was $17,389 in fiscal Q3 2017 (quarter ended Jun 30, 2017), down 86.6% from $129,975 a year earlier.

Analysis

Cel Sci (CVM) Revenue (2010 - 2017) Analysis & Trends

On a trailing twelve-month basis, Cel Sci's Revenue was $255,667 through Jun 30, 2017.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.31 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 16.99 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 15.38 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 7.80 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 15.03 Bn
10 Cel Sci 4.09 Mn -21.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 17,389.00
Jun 30, 2016 129,975.00
Jun 30, 2011 77,403.00
Jun 30, 2010 30,900.00
API Access

Cel Sci Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CVM&period=max&api_key=YOUR_API_KEY